Literature DB >> 30050760

Lung cancer screening: the path forward.

Caroline Chiles1, Reginald F Munden1.   

Abstract

Entities:  

Year:  2018        PMID： 30050760      PMCID： PMC6037961          DOI： 10.21037/tlcr.2018.06.02

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  13 in total

1.  CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases.

Authors:  Rowena Yip; Claudia I Henschke; David F Yankelevitz; James P Smith
Journal:  Radiology       Date:  2014-06-19       Impact factor: 11.105

2.  Computed tomographic screening for lung cancer: an opportunity to evaluate other diseases.

Authors:  Onno M Mets; Pim A de Jong; Mathias Prokop
Journal:  JAMA       Date:  2012-10-10       Impact factor: 56.272

3.  Lung cancer screening as a teachable moment for smoking cessation.

Authors:  Kathryn L Taylor; Lisa Sanderson Cox; Nicole Zincke; Larina Mehta; Colleen McGuire; Edward Gelmann
Journal:  Lung Cancer       Date:  2006-12-28       Impact factor: 5.705

4.  Incidental renal tumours on low-dose CT lung cancer screening exams.

Authors:  Paul F Pinsky; Barbara Dunn; David Gierada; P Hrudaya Nath; Reginald Munden; Lincoln Berland; Barnett S Kramer
Journal:  J Med Screen       Date:  2016-10-09       Impact factor: 2.136

5.  Beyond lung cancer: a strategic approach to interpreting screening computed tomography scans on the basis of mortality data from the National Lung Screening Trial.

Authors:  Caroline Chiles; Narinder S Paul
Journal:  J Thorac Imaging       Date:  2013-11       Impact factor: 3.000

6.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

7.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

8.  Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

Authors:  Nanda Horeweg; Ernst Th Scholten; Pim A de Jong; Carlijn M van der Aalst; Carla Weenink; Jan-Willem J Lammers; Kristiaan Nackaerts; Rozemarijn Vliegenthart; Kevin ten Haaf; Uraujh A Yousaf-Khan; Marjolein A Heuvelmans; Erik Thunnissen; Matthijs Oudkerk; Willem Mali; Harry J de Koning
Journal:  Lancet Oncol       Date:  2014-10-01       Impact factor: 41.316

9.  The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.

Authors:  Nichole T Tanner; Neeti M Kanodra; Mulugeta Gebregziabher; Elizabeth Payne; Chanita Hughes Halbert; Graham W Warren; Leonard E Egede; Gerard A Silvestri
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

10.  Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.

Authors:  David S Gierada; Paul Pinsky; Hrudaya Nath; Caroline Chiles; Fenghai Duan; Denise R Aberle
Journal:  J Natl Cancer Inst       Date:  2014-10-18       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.